Product Segment Analysis: CRT-Defibrillators (Largest Segment) vs CRT-Pacemakers (Fastest-Growing Segment)

The CRT devices market was led by the CRT-defibrillators segment, which accounted for a 79.67% share in 2026. The strong position of this segment is supported by its dual capability of delivering cardiac resynchronization therapy while providing protection against life-threatening ventricular arrhythmias through defibrillation. Physicians often prefer these devices for patients with heart failure who are considered to have an elevated risk of sudden cardiac death, contributing to their widespread clinical adoption. Continuous technological improvements and broader incorporation into treatment guidelines have further reinforced their market leadership.

CRT-pacemakers represent the fastest-growing product segment as healthcare providers increasingly recognize their suitability for patients requiring cardiac resynchronization without the need for implantable defibrillation. Their adoption is expanding among carefully selected patient populations because they provide effective rhythm management while reducing device complexity. Advances in pacing technologies, improved patient selection, and growing awareness of personalized cardiac care are supporting continued growth within this segment.

Age Segment Analysis: 65-84 Years (Largest Segment) vs Above 85 Years (Fastest-Growing Segment)

Individuals aged 65–84 years dominated the CRT devices market, holding a 59.68% share in 2026. This age group represents a substantial proportion of patients affected by heart failure and cardiac conduction disorders, making them primary candidates for cardiac resynchronization therapy. Greater disease awareness, established clinical management pathways, and increasing access to specialized cardiovascular care have contributed to the extensive use of CRT devices among this population.

The above 85 years segment is emerging as the fastest-growing age category due to increasing life expectancy and the growing number of elderly patients receiving advanced cardiovascular interventions. Improvements in procedural safety, comprehensive geriatric assessment, and individualized treatment approaches are enabling clinicians to consider CRT therapy for older patients who can benefit from improved cardiac function and quality of life.

End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Hospitals held the largest share in 2026 within the end-use segment because they possess the specialized infrastructure, experienced electrophysiology teams, and comprehensive diagnostic capabilities required for CRT implantation and long-term patient management. These facilities also manage complex cardiovascular cases and provide multidisciplinary care, making them the preferred setting for advanced cardiac device procedures.

The CRT devices market is experiencing rapid growth in ambulatory surgical centers as healthcare systems increasingly emphasize cost-effective and efficient delivery of specialized procedures. Technological advancements, improvements in minimally invasive implantation techniques, and growing confidence in outpatient cardiac interventions are encouraging a greater number of eligible CRT procedures to be performed in these settings while maintaining high standards of patient care.